Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients

Published 2017 View Full Article

Authors

Keywords

phosphoproteomics, reverse phase protein array (RPPA), ovarian cancer, platinum chemotherapy resistance, response prediction

Journal

Oncotarget

Volume 8, Issue 58, Pages -

Publisher

Impact Journals, LLC

Online

2017-06-09

DOI

10.18632/oncotarget.18415

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now